GLYMAB

Pharmaceutical, therapeutic and medicinal preparations and substances to increase the avidity of antibodies for the treatment of cancer; all the foregoing containing monoclonal antibodies; pharmaceutical compounds for the treatment of cancer, all the foregoing containing monoclonal antibodies